Management of head and neck paragangliomas: Review of 120 patients

Head and Neck

Volumn 31, Issue 3, 2009, Pages 381-387

  Papaspyrou, Konstantinos ^a   Mann, Wolf J ^a   Amedee, Ronald G ^b  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^b OCHSNER CLINIC FOUNDATION   (United States)

Author keywords

Embolization; F DOPA PET; Paraganglioma; Radiotherapy; Recurrence

Indexed keywords

SUCCINATE DEHYDROGENASE;

ADOLESCENT; ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLISM; BENIGN TUMOR; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER SURGERY; CAROTID BODY TUMOR; CEREBROVASCULAR ACCIDENT; CHEMODECTOMA; CHILD; CLINICAL ASSESSMENT; COMPUTER ASSISTED TOMOGRAPHY; CRANIAL NERVE; FACIAL NERVE PARALYSIS; FEMALE; GLOMUS VAGAL TUMOR; HEAD AND NECK CANCER; HORNER SYNDROME; HUMAN; INTERNAL CAROTID ARTERY; JUGULOTYMPANIC TUMOR; MAJOR CLINICAL STUDY; MALE; NERVE PARALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PARAGANGLIOMA; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE COMPLICATION; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; THROMBECTOMY; THROMBOSIS; TUMOR LOCALIZATION; TUMOR VOLUME; TYMPANIC TUMOR; VOCAL CORD PARALYSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CAROTID ARTERY, INTERNAL; CHILD; CRANIAL NERVE DISEASES; DEAFNESS; EMBOLIZATION, THERAPEUTIC; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; OUTCOME ASSESSMENT (HEALTH CARE); PARAGANGLIOMA; POSTOPERATIVE COMPLICATIONS; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 62249136378     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.20967     Document Type: Article

References (45)

1. Milunsky JM, Maher TA, Michels VV, Milunsky A. Novel mutations and the emergence of a common mutation in the SDHD gene causing familial paraganglioma. Am J Med Genet 2001;100:311-314.
2. Mills SE, Gaffey MJ, Frierson HF Jr. Tumors of the upper aerodigestive tract and ear. In: Atlas of tumor pathology, series 3, fasc 26. Washington, DC: Armed Forces Institute of Pathology; 2000.
3. Baysal BE, Farr JE, Rubinstein WS, et al. Fine mapping of an imprinted gene for familial nonchromaffin paragangliomas, on chromosome 11q23. Am J Hum Genet 1997;60:121-132.
4. Manolidis S, Shohet JA, Jackson CG, Glasscock ME III. Malignant glomus tumors. Laryngoscope 1999;109:30-34.
5. Lee JH, Barich F, Karnell LH, et al. National Cancer Data Base report on malignant paragangliomas of the head and neck. Cancer 2002;94:730-737.
6. Baysal BE, Ferrell RE, Willett-Brozick JE, et al. Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science 2000;287:848-851.
7. Niemann S, Müller U. Mutations in SDHC cause autosomal dominant paraganglioma, type 3. Nat Genet 2000;26:268-270.
8. Astuti D, Latif F, Dallol A, et al. Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma. Am J Hum Genet 2001;69:49-54.
9. Baysal BE. Hereditary paraganglioma targets diverse paraganglia. J Med Genet 2002;39:617-622.
10. Young AL, Baysal BE, Deb A, Young WF Jr. Familial malignant catecholamine-secreting paraganglioma with prolonged survival associated with mutation in the succinate dehydrogenase B gene. J Clin Endocrinol Metab 2002;87:4101-4105.
11. Benn DE, Croxson MS, Tucker K, et al. Novel succinate dehydrogenase subunit B (SDHB) mutations in familial pheochromocytomas and paragangliomas, but an absence of somatic SDHB mutations in sporadic pheochromocytomas. Oncogene 2003;22:1358-1364.
12. Gimenez-Roqueplo AP, Favier J, Rustin P, et al. Mutations in the SDHB gene are associated with extra-adrenal and/or malignant pheochromocytomas. Cancer Res 2003;63:5615-5621.
13. van der Mey AG, Maaswinkel-Mooy PD, Cornelisse CJ, Schmidt PH, van de Kamp JJ. Genomic imprinting in hereditary glomus tumours: evidence for new genetic theory. Lancet 1989;2:1291-1294.
14. Hensen EF, Jordanova ES, van Minderhout IJ, et al. Somatic loss of maternal chromosome 11 causes parent-of-origin-dependent inheritance in SDHD-linked paraganglioma and phaeochromocytoma families. Oncogene 2004;23:4076-4083.
15. Margetts CD, Astuti D, Gentle DC, et al. 2005 Epigenetic analysis of HIC1, CASP8, FLIP, TSP1, DCR1, DCR2, DR4, DR5, KvDMR1, H19 and preferential 11p15.5 maternal-allele loss in von Hippel-Lindau and sporadic phaeochromocytomas. Endocr Relat Cancer 2005;12:161-172.
16. Gottlieb E, Tomlinson IP. Mitochondrial tumour suppressors: a genetic and biochemical update. Rev Cancer 2005;5:857-866.
17. Gimm O. Pheochromocytoma-associated syndromes: genes, proteins and functions of RET, VHL and SDHx. Familial Cancer 2005;4:17-23.
18. Maxwell PH. A common pathway for genetic events leading to pheochromocytoma. Cancer Cell 2005;8:91-93.
19. Cole JM, Beiler D. Long-term results of treatment of glomus jugulare and glomus vagale tumors with radiotherapy. Laryngoscope 1994;104:1461-1465.
20. Foote RL, Pollock BE, Gorman DA, et al. Glomus jugulare tumor: tumor control and complications after stereotactic radiosurgery. Head Neck 2002;24:332-338.
21. Renard L, Godfraind C, Boon LM, Vikkula M. A novel mutation in the SDHD gene in a family with inherited paragangliomas - implications of genetic diagnosis for follow-up and treatment. Head Neck 2003;25:146-151.
22. Kasper GC, Welling RE, Wladis AR, et al. A multidisciplinary approach to carotid paragangliomas. Vasc Endovascular Surg 2006-2007;40:467-474.
23. Luna-Ortiz K, Rascon-Ortiz M, Villavicencio-Valencia V, Granados-Garcia M, Herrera-Gomez A. Carotid body tumors: review of a 20-year experience. Oral Oncol 2005;41:56-61.
24. Zanoletti E, Mazzoni A. Vagal paraganglioma. Skull Base 2006;16:161-167.
25. Netterville JL, Jackson CG, Miller FR, Wanamaker JR, Glasscock ME. Vagal paraganglioma: a review of 46 patients treated during a 20-year period. Arch Otolaryngol Head Neck Surg 1998;124:1133-1140.
26. Urquhart AC, Johnson JT, Myers EN, Schechter GL. Glomus vagale: paraganglioma of the vagus nerve. Laryngoscope 1994;104:440-445.
27. Browne JD, Fisch U, Valavanis A. Surgical therapy of glomus vagale tumors. Skull Base Surg 1993;3:182-192.
28. Moe KS, Li D, Linder TE, Schmid S, Fisch U. An update on the surgical treatment of temporal bone paraganglioma. Skull Base Surg 1999;9:185-194.
29. Brown JS. Glomus jugulare tumors revisited: a ten year statistical follow-up of 231 cases. Laryngoscope 1985;95:284-288.
30. Sanna M, Jain Y, De Donato G, Rohit , Lauda L, Taibah A. Management of jugular paragangliomas: the Gruppo Otologico experience. Otol Neurotol 2004;25:797-804.
31. Pellitteri PK, Rinaldo A, Myssiorek D, et al. Paragangliomas of the head and neck. Oral Oncol 2004;40:563-575.
32. Kollert M, Minovi AA, Draf W, Bockmühl U. Cervical paragangliomas - tumor control and long-term functional results after surgery. Skull Base 2006;16:185-191.
33. Neumann HPH, Pawlu C, Peczkowska M, et al. Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations. JAMA 2004;292:943-951.
34. Green JD Jr, Brackmann DE, Nguyen CD, Arriaga MA, Telischi FF, De la Cruz A. Surgical management of previously untreated glomus jugulare tumors. Laryngoscope 1994;104:917-921.
35. Gottfried ON, Liu JK, Couldwell WT. Comparison of radiosurgery and conventional surgery for the treatment of glomus jugulare tumors. Neurosurg Focus 2004;17:E4.
36. Antonitsis P, Saratzis N, Velissaris I. Management of cervical paragangliomas: review of a 15-year experience. Langenbecks Arch Surg 2006;391:396-402.
37. Hinerman RW, Mendenhall WM, Amdur RJ, Stringer SP, Antonelli PJ, Cassisi NJ. Definitive radiotherapy in the management of chemodectomas arising in the temporal bone, carotid body and glomus vagale. Head Neck 2001;23:363-371.
38. Evenson LJ, Mendenhall WM, Parsons JT, Cassisi NJ. Radiotherapy in the management of chemodectomas of the carotid body and glomus vagale. Head Neck 1998;20:609-613.
39. Valdagni R, Amichetti M. Radiation therapy of carotid body tumors. Am J Clin Oncol 1990;13:45-48.
40. Elsaikh MA, Mahmoud-Ahmed AS, Kinney SE, et al. Recurrent head-and-neck chemodectomas: a comparison of surgical and radiotherapeutic results. Int J Radiat Oncol Biol Phys 2002;52:953-956.
41. Spector GJ, Maisel RH, Ogura JH. Glomus jugulare tumors. II. A clinicopathologic analysis of the effects of radiotherapy. Ann Otol Rhinol Laryngol 1974;83:26-32.
42. Spector GJ, Compagno J, Perez CA, Maisel RH, Ogura JH. Glomus jugulare tumors: effects of radiotherapy. Cancer 1975;35:1316-1327.
43. Benn DE, Gimenez-Roqueplo AP, Reilly JR, et al. Clinical presentation and penetrance of pheochromocytoma/paraganglioma syndromes. J Clin Endocrinol Metab 2006;91:827-836.
44. Papaspyrou K, Rossmann H, Fottner C, et al. Malignant paraganglioma caused by a novel germline mutation of the succinate dehydrogenase D-gene - a case report. Head Neck 2008;30:964-969.
45. Hoegerle S, Ghanem N, Altehoefer C, et al. 18F-DOPA positron emission tomography for the detection of glomus tumours. Eur J Nucl Med Mol Imaging 2003;30:689-694.